Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 5 results for "combiflam"

Sanofi India banks on Rajaram's FMCG expertise
Business Today India

Sanofi India banks on Rajaram's FMCG expertise

N Rajaram Selling shampoo is different from selling a pain killer or a drug for the central nervous system. Most in the Indian pharma industry would also say so. They would concur with the head of a leading pharma company in Mumbai who told ... Business Today India, 1 day ago

FDA move on prescription drugs causes more pain than cure

A 65-year-old Pune resident, who was in Mumbai, had a tough time buying her hypertension medicines, which she had forgotten to pack. For three hours, she kept visiting chemist shops in the city but no one sold her the medicine as she didn't have ...
 DNA India1 week ago

Buy Sanofi India; target of Rs 2890: Firstcall Research

Brokerage house Firstcall Research is bullish on Sanofi India and has recommended buy rating on the stock with a target price of Rs 2890 in its research report dated March 07, 2014. Firstcall Research report on Sanofi India Sanofi, an ...
 Moneycontrol.com1 month ago

Midnight indulgences delivered at doorstep

Imagine you are lazing around after a late night conversation with your boyfriend or have been working till the wee hours for your research project or simply, you are in the middle of a house party. Hunger pangs are bothering you or you are craving for the ...
 Asian Age2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less